RE:RE:Equity Guru new article out on PMED Actually COO Rahul has stated on multiple occassions that a a buyout is PMEDs ultimate goal.
Having Kapil Raval on our Advisory Board to help solidify major contracts for us will for sure put us firmly on Microsoft's radar.
I think what many here are also thinking but having a hard time fully believing or just articulating is just how absolutely HUGE this thing can be on so many different levels, on a full global scale AND also the fact that they have a monopoly on each one of their technologies.
A great balance sheet with no debt and 2 years worth of cash in the bank is just icing on the cake. It's amazing how relatively easy everything is seemingly coming together. It just doesn't quite seem real....yet.
The fact that all they have to do is "tweak" a technology for it to do something new like detect impairment of a new drug, is just one more technology monopoly they will have to dominate the world with. It is somewhat mind boggling.
Sure they would have to go through clinical studies just like they are doing now with marijuana but after they have the first one nailed down with Hindalco, they can use that as a template to create a faster more efficient study for further drug impairment detection technologies. I'm sure Hindalco doesn't want their employees on Meth or Cocaine etc. either. PMED could then offer up a "Premium Priced Drug Impairment Detection Deluxe Package". What heavy equipment operating employer wouldn't want that?
Before the end of this summer, once studies are published and courts can access them, Law Enforcement from everywhere will be coming on board wanting this. If Blo and Hound can have multi-million dollar market caps and haven't even got working units out in the field imagine what people would pay for us...something that works and works well.
Then Tech Mahindra will do their thing around the world in the 91 countries they have a presence in. The stock price will snowball very fast from there with each new contract they get.
If I'm thinking these things, of course Microsoft is already thinking these things too. A $2B offer for PMED from a $1.44 trillion dollar company to dominate the world in new AI technologies is a drop in the bucket for them. That would put us at $20/share but I'm even starting to think that this would be a lowball price for what PMED has.
COVID mass screening alone, something capable of getting entire countries' economies back on track, is enough to send this thing infinitely higher.
If Microsoft isn't looking at us yet, then I can't think of what else on earth they would be more interested in looking at.